Skip to main content
Premium Trial:

Request an Annual Quote

MGH Group to Use OriGene s cDNA Collection

NEW YORK, July 25 (GenomeWeb News) - A research group at Massachusetts General Hospital will use OriGene Technologies' cDNA clone collection for high-throughput functional gene analyses, the Rockville, Md.-based company said today.


Under the collaboration, scientist in the laboratory of Brian Seed, a professor of genetics at HarvardMedicalSchooland director of the Center for Computational and Integrative Biology at MGH, will use OriGene's FlagArray full-length cDNAs in expression vectors. The research group will also help OriGene to further develop the platform.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.